Skip to main content
Eurostyle Collection Lisboa Table Lamp by Gilt <img src="https://chart.googleapis.com/chart?cht=qr&chs=200x200&chl=https%3A%2F%2Fapi.shopstyle.com%2Faction%2FapiVisitRetailer%3Fid%3D687775003%26pid%3Duid1456-40284116-11%26utm_content%3Dqr-code">
Post a Comment

ALL ABOUT MS Pregnancy and MS (Part 13)

ALL ABOUT MS Pregnancy and MS (Part 13)

Given that MS is largely a disease of women, and also of young women, there is a special topic of the relationship between this disease and pregnancy, or birth.


MS does not increase the risk of complications during pregnancy. It has not been shown that there is an increased incidence of preterm delivery, birth defects, inborn deformations, or early death of the newborn. However, exceptions are possible.


Delivery in women with MS does not differ from birth in healthy women. The method of delivery is determined by the gynecologist according to gynecological criteria. Previously, spinal anesthesia was thought to increase the risk of postpartum deterioration, but the use of modern epidural anesthesia is considered safe and has not been shown to increase the risk of deterioration after delivery.


Breastfeeding is recommended and does not increase the risk of deterioration. However, caution is needed if mothers take medicines that are secreted through milk. Breastfeeding is forbidden if the mother receives corticosteroids or mitoxantrone and is not recommended during interferon beta therapy and glatiramer acetate, as it is not known whether these drugs are excreted via breast milk.

It is known that pregnancy works favorably on the course of MS, reducing the risk of deterioration, which is particularly pronounced in the first trimester of pregnancy. On the other hand, the risk of MS worsening is rising immediately after delivery, especially in the first three months after delivery. It has not been shown that deterioration of MS during pregnancy and postpartum is more severe than other illnesses during illness. In the long term, the number of pregnancies and the way of delivery have no effect on the development of the disease and its progression. In any case, women with MS, especially those with mild neurological outbreaks, should be encouraged to establish a family as early as possible for a possible progressive course of the disease.
Labels:

Comments

Post a Comment

Popular posts from this blog

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS  Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...
Post a Comment
Read more

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...
Post a Comment
Read more

ALL ABOUT MS Symptoms of MS (Part 4)

Urinary disorders About one-third of patients have sphincter disorders: an overwhelming need for urinary incontinence, which can sometimes be accompanied by frequent urination (so-called polacizuria), difficulty in urinating, retention (complete inability to urinate) and incontinence (loss of control over the process urinating, so that the urinary bladder empties reluctantly and unexpectedly). Urinary disorders can be accompanied by constipation and incontinence of the stool and impotence. Urinary disorders are very disturbing disorders, which significantly affect the quality of life, personal, professional and social functioning of the patients. Urinary disorders in MS are very common and occur in approximately 96% of patients with MS after 10 years of illness. Urinary disorders can occur at any time during the course of the disease, even at its inception (in about 2% of patients). Some researchers believe that patients in whom the disease begins with problems in the...
Post a Comment
Read more